S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function

M A Hoyt1, L Totis, B T Roberts

  • 1Department of Biology, Johns Hopkins University, Baltimore, Maryland 21218.

Cell
|August 9, 1991
PubMed

Insights

Researchers identified mutant yeast strains that cannot halt cell division when microtubules are disrupted. These mutants continue DNA replication and budding, indicating a failure in the cell cycle surveillance system for microtubule function.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Cell cycle progression relies on accurate chromosome segregation, monitored by surveillance mechanisms.
  • Microtubules are crucial components of the mitotic spindle, ensuring proper chromosome segregation.
  • Loss of microtubule function typically triggers cell cycle arrest to prevent errors.

Purpose of the Study:

  • To identify genes involved in the cell cycle arrest response to microtubule disruption in Saccharomyces cerevisiae.
  • To characterize the phenotype of yeast mutants that fail to arrest their cell cycle under microtubule-perturbing conditions.

Main Methods:

  • Isolation and characterization of temperature-sensitive mutant strains of S. cerevisiae.
  • Microscopy to assess cell cycle progression, bud emergence, and DNA replication.
  • Measurement of histone H1 kinase activity under various cell cycle-blocking conditions.

Main Results:

  • Identified three genes essential for cell cycle arrest upon microtubule disruption.
  • Mutant strains exhibited continued DNA replication and new bud emergence despite loss of microtubule function.
  • Mutants failed to maintain elevated histone H1 kinase activity characteristic of wild-type arrest.
  • The cell cycle defect was specific to microtubule perturbation, with normal responses to other arrest stimuli.

Conclusions:

  • The findings support the existence of a specific surveillance pathway that monitors microtubule integrity.
  • This pathway is critical for halting cell cycle progression to prevent genetic instability.
  • The identified genes are key components of this essential cell cycle checkpoint mechanism.

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K